Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).

<h4>Introduction</h4>Short stature is a frequent complication of DMD, and its pathomechanisms and influencing factors are specific to this disease and the idiosyncratic treatment for DMD.<h4>Purpose</h4>To establish the height growth curve of early DMD, and evaluate the poten...

Full description

Saved in:
Bibliographic Details
Main Authors: Bingying Wang, Linyuhan Zhou, Shuangru Li, Huayan Xu, Yingkun Guo, Qin Hu, Min Huang, Dan Zhou, Xiaotang Cai, Qiu Wang, Xiaomei Sun
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0316938
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533255740817408
author Bingying Wang
Linyuhan Zhou
Shuangru Li
Huayan Xu
Yingkun Guo
Qin Hu
Min Huang
Dan Zhou
Xiaotang Cai
Qiu Wang
Xiaomei Sun
author_facet Bingying Wang
Linyuhan Zhou
Shuangru Li
Huayan Xu
Yingkun Guo
Qin Hu
Min Huang
Dan Zhou
Xiaotang Cai
Qiu Wang
Xiaomei Sun
author_sort Bingying Wang
collection DOAJ
description <h4>Introduction</h4>Short stature is a frequent complication of DMD, and its pathomechanisms and influencing factors are specific to this disease and the idiosyncratic treatment for DMD.<h4>Purpose</h4>To establish the height growth curve of early DMD, and evaluate the potential influencing markers on height growth, provide further evidence for pathological mechanism, height growth management and bone health in DMD.<h4>Methods</h4>A retrospective, cross-sectional study of 348 participants with DMD aged 2-12 years was conducted at West China Second Hospital of Sichuan University from January 2023 to October 2023.<h4>Results</h4>The growth curve for 2-12 years old boys with DMD indicates a slower growth rate compared to the average population. At age two, children with DMD have a similar height to their peers, but gradually falls behind afterwards. Short stature was observed in children with DMD before and after GC exposure, and prolonged GC use exacerbated the retardation. BMI (β = -0.47, p = 0.007), BMD (β = -0.005, p = 0.014), β-CTX (β = 0.001, p = 0.002), delayed BA (β = 0.417, p < .001), GC duration (β = -0.006, p = 0.047) were independent influencing factors of height. Relevant bone health markers showed different sequential changing patterns.<h4>Conclusion</h4>The high proportion and progression of short stature are associated with the broad bone health status. Different bone indicators have different sensitivities and specificities and need to be considered together for clinical monitoring of bone health. This study provides evidence for the early monitoring of height development and relevant factors as part of bone health management in DMD, to minimize the occurrence of bone-related complications later in life.
format Article
id doaj-art-af4f982c3ae440a8a1ed634538194fd7
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-af4f982c3ae440a8a1ed634538194fd72025-01-17T05:31:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031693810.1371/journal.pone.0316938Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).Bingying WangLinyuhan ZhouShuangru LiHuayan XuYingkun GuoQin HuMin HuangDan ZhouXiaotang CaiQiu WangXiaomei Sun<h4>Introduction</h4>Short stature is a frequent complication of DMD, and its pathomechanisms and influencing factors are specific to this disease and the idiosyncratic treatment for DMD.<h4>Purpose</h4>To establish the height growth curve of early DMD, and evaluate the potential influencing markers on height growth, provide further evidence for pathological mechanism, height growth management and bone health in DMD.<h4>Methods</h4>A retrospective, cross-sectional study of 348 participants with DMD aged 2-12 years was conducted at West China Second Hospital of Sichuan University from January 2023 to October 2023.<h4>Results</h4>The growth curve for 2-12 years old boys with DMD indicates a slower growth rate compared to the average population. At age two, children with DMD have a similar height to their peers, but gradually falls behind afterwards. Short stature was observed in children with DMD before and after GC exposure, and prolonged GC use exacerbated the retardation. BMI (β = -0.47, p = 0.007), BMD (β = -0.005, p = 0.014), β-CTX (β = 0.001, p = 0.002), delayed BA (β = 0.417, p < .001), GC duration (β = -0.006, p = 0.047) were independent influencing factors of height. Relevant bone health markers showed different sequential changing patterns.<h4>Conclusion</h4>The high proportion and progression of short stature are associated with the broad bone health status. Different bone indicators have different sensitivities and specificities and need to be considered together for clinical monitoring of bone health. This study provides evidence for the early monitoring of height development and relevant factors as part of bone health management in DMD, to minimize the occurrence of bone-related complications later in life.https://doi.org/10.1371/journal.pone.0316938
spellingShingle Bingying Wang
Linyuhan Zhou
Shuangru Li
Huayan Xu
Yingkun Guo
Qin Hu
Min Huang
Dan Zhou
Xiaotang Cai
Qiu Wang
Xiaomei Sun
Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).
PLoS ONE
title Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).
title_full Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).
title_fullStr Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).
title_full_unstemmed Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).
title_short Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).
title_sort height development and multiple bone health indicators in children aged 2 12 years with duchenne muscular dystrophy dmd
url https://doi.org/10.1371/journal.pone.0316938
work_keys_str_mv AT bingyingwang heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT linyuhanzhou heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT shuangruli heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT huayanxu heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT yingkunguo heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT qinhu heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT minhuang heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT danzhou heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT xiaotangcai heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT qiuwang heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd
AT xiaomeisun heightdevelopmentandmultiplebonehealthindicatorsinchildrenaged212yearswithduchennemusculardystrophydmd